rs2043635

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014669.5(NUP93):​c.298-13401A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.31 in 152,108 control chromosomes in the GnomAD database, including 7,675 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 7675 hom., cov: 32)

Consequence

NUP93
NM_014669.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.247

Publications

3 publications found
Variant links:
Genes affected
NUP93 (HGNC:28958): (nucleoporin 93) The nuclear pore complex is a massive structure that extends across the nuclear envelope, forming a gateway that regulates the flow of macromolecules between the nucleus and the cytoplasm. Nucleoporins are the main components of the nuclear pore complex in eukaryotic cells. This gene encodes a nucleoporin protein that localizes both to the basket of the pore and to the nuclear entry of the central gated channel of the pore. The encoded protein is a target of caspase cysteine proteases that play a central role in programmed cell death by apoptosis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2016]
NUP93 Gene-Disease associations (from GenCC):
  • nephrotic syndrome, type 12
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_014669.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.448 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014669.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NUP93
NM_014669.5
MANE Select
c.298-13401A>G
intron
N/ANP_055484.3
NUP93
NM_001242795.2
c.-73+2861A>G
intron
N/ANP_001229724.1Q8N1F7-2
NUP93
NM_001242796.2
c.-73+1203A>G
intron
N/ANP_001229725.1Q8N1F7-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NUP93
ENST00000308159.10
TSL:1 MANE Select
c.298-13401A>G
intron
N/AENSP00000310668.5Q8N1F7-1
NUP93
ENST00000569842.5
TSL:5
c.298-13401A>G
intron
N/AENSP00000458101.1H3BVG0
NUP93
ENST00000923937.1
c.298-13401A>G
intron
N/AENSP00000593996.1

Frequencies

GnomAD3 genomes
AF:
0.310
AC:
47161
AN:
151990
Hom.:
7673
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.383
Gnomad AMI
AF:
0.117
Gnomad AMR
AF:
0.309
Gnomad ASJ
AF:
0.213
Gnomad EAS
AF:
0.463
Gnomad SAS
AF:
0.366
Gnomad FIN
AF:
0.225
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.272
Gnomad OTH
AF:
0.312
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.310
AC:
47190
AN:
152108
Hom.:
7675
Cov.:
32
AF XY:
0.311
AC XY:
23136
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.383
AC:
15877
AN:
41490
American (AMR)
AF:
0.308
AC:
4714
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
739
AN:
3472
East Asian (EAS)
AF:
0.463
AC:
2393
AN:
5166
South Asian (SAS)
AF:
0.366
AC:
1763
AN:
4818
European-Finnish (FIN)
AF:
0.225
AC:
2377
AN:
10580
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.272
AC:
18467
AN:
67976
Other (OTH)
AF:
0.314
AC:
664
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1636
3272
4908
6544
8180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
478
956
1434
1912
2390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.289
Hom.:
828
Bravo
AF:
0.321
Asia WGS
AF:
0.408
AC:
1418
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
2.4
DANN
Benign
0.55
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2043635;
hg19: chr16-56818987;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.